These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24384037)

  • 1. Complex railroad track appearance on interval plot for an implantable cardioverter defibrillator shock episode: what is the mechanism?
    Akerström F; Arias MA; Pachón M; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):660-3. PubMed ID: 24384037
    [No Abstract]   [Full Text] [Related]  

  • 2. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies.
    Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M
    Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wide QRS complex tachycardia in a patient with a biventricular implantable cardioverter defibrillator: what is the mechanism?
    Arias MA; Puchol A; Pachón M; Briz C
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):334-7. PubMed ID: 24237963
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic polymorphic ventricular tachycardia with normal QT interval requiring implantable cardioverter-defibrillator device.
    Gambhir DS; Salwan R; Sharma VP; Kaul UA; Arora R
    Indian Heart J; 1996; 48(3):292-4. PubMed ID: 8755022
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
    Strohmer B; Schernthaner C; Pichler M
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):244-6. PubMed ID: 15028059
    [No Abstract]   [Full Text] [Related]  

  • 7. A completely subcutaneous implantable cardioverter defibrillator system functioning simultaneously with an endocardial implantable cardioverter defibrillator programmed as pacemaker.
    van Opstal J; Geskes G; Debie L
    Europace; 2011 Jan; 13(1):141-2. PubMed ID: 20587539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device.
    Manolis AG; Kourouklis S; Chatzis D; Kouvelas K; Kyriakides Z
    Cardiol J; 2008; 15(3):281-3. PubMed ID: 18651422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.
    Schukro C; Leitner L; Siebermair J; Pezawas T; Stix G; Kastner J; Schmidinger H
    Int J Cardiol; 2013 Sep; 167(6):3006-10. PubMed ID: 23017814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wide complex tachycardia in a patient with a dual-chamber defibrillator: what is the rhythm? A tale of timing cycles.
    Thajudeen A; Kannarkat V; Noheria A; Shehata M
    Heart Rhythm; 2013 Aug; 10(8):1237-9. PubMed ID: 23562698
    [No Abstract]   [Full Text] [Related]  

  • 12. An electrical storm with more than 3000 shocks in a patient with an implantable cardioverter-defibrillator: is jet-lag a trigger?
    Han SW; Kim YN; Lee YS; Hyun DW; Kim D; Hur SH; Kim KS; Kim KB
    Int J Cardiol; 2005 Sep; 104(2):235-7. PubMed ID: 16168822
    [No Abstract]   [Full Text] [Related]  

  • 13. Tachycardia-induced cardiomyopathy unmasked with implantable cardioverter defibrillator implantation.
    Danon A; Singh SM
    Can J Cardiol; 2013 Oct; 29(10):1330.e9-1330.e10. PubMed ID: 23993688
    [No Abstract]   [Full Text] [Related]  

  • 14. [ICD programming and algorithms 2016].
    Israel CW
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):161-2. PubMed ID: 27576694
    [No Abstract]   [Full Text] [Related]  

  • 15. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion.
    Duru F; Bauersfeld U; Candinas R
    Europace; 2001 Jan; 3(1):80-4. PubMed ID: 11271957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transesophageal ventricular stimulation and ventricular tachycardia in the period before implantation of a cardioverter-defibrillator].
    Pella J; Bodnár J; Stancák B; Misíkoá S; Sedlák J; Cizmárik P
    Vnitr Lek; 1994 Oct; 40(10):663-6. PubMed ID: 7810086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual indication for subcutaneous implantable -cardioverter/defibrillator.
    De Schryver N; van Ruyssevelt C; Capulzini L
    Acta Cardiol; 2017 Aug; 72(4):487-488. PubMed ID: 28705110
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of different antitachycardia pacing sites in the termination of ventricular tachycardia in patients with biventricular implantable cardioverter-defibrillator.
    Haghjoo M; Hajahmadi M; Fazelifar AF; Sadr-Ameli MA
    Europace; 2011 Apr; 13(4):509-13. PubMed ID: 21296776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.